09034376 is referenced by 16 patents and cites 264 patents.

Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.

Title
Pharmaceutical formulation containing gelling agent
Application Number
14/460134
Publication Number
9034376 (B2)
Application Date
August 14, 2014
Publication Date
May 19, 2015
Inventor
Christopher Breder
Bethesda
MD, US
Benjamin Oshlack
Boca Raton
FL, US
Curtis Wright
Rockport
MA, US
Agent
Lowenstein Sandler
Assignee
Purdue Pharmaceuticals
NC, US
The P F Laboratories
NJ, US
Purdue Pharma
CT, US
IPC
A61K 47/26
A61K 9/16
A61K 31/192
A61K 45/06
A61K 47/10
A61K 47/36
A61K 47/38
A61K 31/485
A61K 31/439
A61K 9/00
A61K 31/167
A61K 9/20
View Original Source